potensi tumbuhan kerokot (lygodium microphylum) dalam bidang kefarmasian
Clicks: 140
ID: 185305
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
140 views
12 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #22 of 23 articles by views in Кантовский сборник
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Tumbuhan Kerokot (Lygodium microphylum) di Kalimantan Timur masih dianggap sebagai gulma karena pertumbuhannya yang sangat cepat dan meluas kesegala arah pada suatu lahan sehingga mengganggu lahan petani jika tumbuh pada lahan perkebunan/ladang petani. Telah dilakukan skrining beberapa potensi kefarmasian terhadap ekstrak Herba Kerokot (Lygodium microphylum) dan terbukti memliki potensi sebagai antioksidan, penumbuh rambut, larvasida untuk nymuk Culex sp dan Aedes aegypty, dan obat luka. Potensi terbaik dari hasil-hasil penelitian tersebut adalah sebagai penumbuh rambut yang telah dilakukan pada hewan uji.
Kata Kunci: Lygodium microphylum, potensi kefarmasian
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (87 words).
Try re-searching for a better abstract.
| Reference Key |
rijai2012journalpotensi
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Laode Rijai |
| Journal | Кантовский сборник |
| Year | 2012 |
| DOI |
10.25026/jtpc.v2i1.46
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.